Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center’s experience-Reference-Cited by-同舟云学术

Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center’s experience

Published:2018-07-03 Issue:3 Volume:25 Page:197-202
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Ikram Asad¹^ORCID,Donnelly Joseph P.¹^ORCID,Sperry Brett W.¹,Samaras Christy²,Valent Jason²^ORCID,Hanna Mazen¹

Affiliation:

1. Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA;

2. Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2018.1519507

Reference28 articles.

1. Cardiac amyloidosis: An update on diagnosis and treatment

2. Transthyretin as a Thyroid Hormone Carrier: Function Revisited

3. Synthesis of Thyroid Hormone Binding Proteins Transthyretin and Albumin by Human Trophoblast

4. Are classic predictors of voltage valid in cardiac amyloidosis? A contemporary analysis of electrocardiographic findings

5. Sekijima Y, Yoshida K, Tokuda T, et al. Familial transthyretin amyloidosis. 2001 Nov 5 [Updated 2012 Jan 26]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017. Available from: https://www-ncbi-nlm-nih-gov.ccmain.ohionet.org/books/NBK1194/.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects;Seminars in Nuclear Medicine;2024-09

2. Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot Study;Journal of Clinical Medicine;2024-08-25

3. Pharmacological management of transthyretin amyloid cardiomyopathy: a scoping review;European Heart Journal - Cardiovascular Pharmacotherapy;2024-06-03

4. Safety and efficacy of diflunisal in transthyretin cardiac amyloidosis;Revista Española de Cardiología (English Edition);2024-05

5. Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis;Heart and Vessels;2024-04-05